Financial Ratios Ryan Specialty Holdings, Inc.
Equities
RYAN
US78351F1075
Multiline Insurance & Brokers
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.56 USD | +0.15% |
|
+0.69% | -23.47% |
| Feb. 25 | BMO Capital Downgrades Ryan Specialty to Market Perform From Outperform, Cuts Price Target to $43 From $66 | MT |
| Feb. 25 | Analyst recommendations: IBM, Axon, Caterpillar, Fair Isaac, Gilead… |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Profitability | |||||||
Return on Assets | 3.09 | 3.26 | 3.5 | 3.69 | 3.54 | ||
Return on Total Capital | 7.16 | 7.35 | 7.81 | 8.11 | 7.66 | ||
Return On Equity % | 12.16 | 23.11 | 21.64 | 22.13 | 18.21 | ||
Return on Common Equity | -3.42 | 15.05 | 11.76 | 15.94 | 9.94 | ||
Margin Analysis | |||||||
Gross Profit Margin % | 34.14 | 35.39 | 35.93 | 38.48 | 41.84 | ||
SG&A Margin | 9.05 | 10.95 | 11.37 | 11.31 | 13.1 | ||
EBITDA Margin % | 25.09 | 24.44 | 24.55 | 27.16 | 28.74 | ||
EBITA Margin % | 24.75 | 24.1 | 24.11 | 26.76 | 28.3 | ||
EBIT Margin % | 17.22 | 18.05 | 18.84 | 20.34 | 19.14 | ||
Income From Continuing Operations Margin % | 3.95 | 9.54 | 9.6 | 9.36 | 7.15 | ||
Net Income Margin % | 4.6 | 3.57 | 3.01 | 3.85 | 2.12 | ||
Net Avail. For Common Margin % | -0.49 | 3.61 | 3.01 | 3.85 | 2.12 | ||
Normalized Net Income Margin | 6.35 | 1.77 | 3.12 | 4.92 | 4.09 | ||
Levered Free Cash Flow Margin | -3.9 | 13.45 | 17.46 | 20.49 | 16.9 | ||
Unlevered Free Cash Flow Margin | -1.19 | 16.65 | 21.22 | 23.78 | 21.07 | ||
Asset Turnover | |||||||
Asset Turnover | 0.29 | 0.29 | 0.3 | 0.29 | 0.3 | ||
Fixed Assets Turnover | 13.54 | 12.44 | 11.74 | 13.89 | 15.62 | ||
Receivables Turnover (Average Receivables) | 7.37 | 7.73 | 7.71 | 7.18 | 6.82 | ||
Short Term Liquidity | |||||||
Current Ratio | 1.04 | 1.24 | 1.16 | 1.05 | 0.98 | ||
Quick Ratio | 0.21 | 0.4 | 0.31 | 0.22 | 0.13 | ||
Operating Cash Flow to Current Liabilities | 0.09 | 0.11 | 0.13 | 0.11 | 0.12 | ||
Days Sales Outstanding (Average Receivables) | 49.52 | 47.2 | 47.33 | 50.97 | 53.55 | ||
Average Days Payable Outstanding | 26.67 | 32.01 | 29.4 | 38.58 | 42.78 | ||
Long Term Solvency | |||||||
Total Debt/Equity | 275.5 | 263.77 | 219.98 | 315.42 | 281.55 | ||
Total Debt / Total Capital | 73.37 | 72.51 | 68.75 | 75.93 | 73.79 | ||
LT Debt/Equity | 268.59 | 257.25 | 214.19 | 308.7 | 274.67 | ||
Long-Term Debt / Total Capital | 71.53 | 70.72 | 66.94 | 74.31 | 71.99 | ||
Total Liabilities / Total Assets | 88.81 | 87.19 | 86.48 | 88.62 | 88.13 | ||
EBIT / Interest Expense | 3.08 | 2.89 | 2.7 | 2.98 | 2.67 | ||
EBITDA / Interest Expense | 4.79 | 4.22 | 3.78 | 4.17 | 4.17 | ||
(EBITDA - Capex) / Interest Expense | 0.38 | 4.01 | 3.57 | 3.89 | 3.84 | ||
Total Debt / EBITDA | 4.39 | 4.78 | 4.03 | 4.96 | 3.94 | ||
Net Debt / EBITDA | 3.38 | 2.58 | 2.46 | 4.16 | 3.76 | ||
Total Debt / (EBITDA - Capex) | 55.04 | 5.03 | 4.27 | 5.31 | 4.27 | ||
Net Debt / (EBITDA - Capex) | 42.39 | 2.72 | 2.61 | 4.46 | 4.08 | ||
Growth Over Prior Year | |||||||
Total Revenues, 1 Yr. Growth % | 40.87 | 19.53 | 18.39 | 21.17 | 21.95 | ||
Gross Profit, 1 Yr. Growth % | 36.38 | 23.91 | 20.18 | 29.77 | 28.25 | ||
EBITDA, 1 Yr. Growth % | 34.2 | 16.43 | 18.95 | 34.05 | 23.08 | ||
EBITA, 1 Yr. Growth % | 34.38 | 16.4 | 18.4 | 34.53 | 22.93 | ||
EBIT, 1 Yr. Growth % | 23.16 | 25.31 | 23.54 | 30.81 | 7.81 | ||
Earnings From Cont. Operations, 1 Yr. Growth % | -19.69 | 188.28 | 19.12 | 18.22 | -6.85 | ||
Net Income, 1 Yr. Growth % | -3.28 | -7.32 | -0.02 | 55.09 | -33.03 | ||
Normalized Net Income, 1 Yr. Growth % | 20.7 | -66.67 | 100.19 | 91.14 | -13.04 | ||
Diluted EPS Before Extra, 1 Yr. Growth % | -179.08 | -838.45 | 0.33 | 37.73 | -34.86 | ||
Accounts Receivable, 1 Yr. Growth % | 18.68 | 9.93 | 27.12 | 32.48 | 25.45 | ||
Net Property, Plant and Equip., 1 Yr. Growth % | -10.06 | 74.85 | -2.86 | 7.83 | 8.98 | ||
Total Assets, 1 Yr. Growth % | 20.52 | 16.95 | 13.53 | 33.15 | 9.47 | ||
Tangible Book Value, 1 Yr. Growth % | -12.49 | -14.06 | 28.3 | 105.89 | 19.99 | ||
Common Equity, 1 Yr. Growth % | 392.58 | 39.16 | 17 | 12.13 | 3.25 | ||
Cash From Operations, 1 Yr. Growth % | 102 | 22.68 | 42.23 | 7.89 | 25.02 | ||
Capital Expenditures, 1 Yr. Growth % | 1.89K | -93.55 | 30.84 | 57.85 | 50.99 | ||
Levered Free Cash Flow, 1 Yr. Growth % | -115.41 | -682.39 | 40.36 | 42.2 | -3.26 | ||
Unlevered Free Cash Flow, 1 Yr. Growth % | -104.39 | -33.57K | 39.63 | 35.77 | 4.46 | ||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | 9.09 | ||
Compound Annual Growth Rate Over Two Years | |||||||
Total Revenues, 2 Yr. CAGR % | 37.42 | 29.76 | 18.96 | 19.77 | 21.56 | ||
Gross Profit, 2 Yr. CAGR % | 34.23 | 30 | 22.03 | 24.88 | 27.3 | ||
EBITDA, 2 Yr. CAGR % | 46.57 | 25 | 17.68 | 26.28 | 25.92 | ||
EBITA, 2 Yr. CAGR % | 47.72 | 25.07 | 17.4 | 26.21 | 26.01 | ||
EBIT, 2 Yr. CAGR % | 46.99 | 24.23 | 24.42 | 27.12 | 15.86 | ||
Earnings From Cont. Operations, 2 Yr. CAGR % | -5.23 | 52.16 | 85.31 | 18.67 | 4.94 | ||
Net Income, 2 Yr. CAGR % | 1.32 | -5.32 | -3.74 | 24.52 | 1.92 | ||
Normalized Net Income, 2 Yr. CAGR % | 33.46 | -36.58 | -16.87 | 95.61 | 15.76 | ||
Diluted EPS Before Extra, 2 Yr. CAGR % | - | 141.65 | 172.19 | 17.55 | -5.28 | ||
Accounts Receivable, 2 Yr. CAGR % | 28.79 | 14.22 | 18.11 | 29.78 | 28.92 | ||
Net Property, Plant and Equip., 2 Yr. CAGR % | 194.35 | 25.41 | 30.33 | 2.35 | 8.41 | ||
Total Assets, 2 Yr. CAGR % | 57.87 | 18.72 | 15.22 | 22.95 | 20.73 | ||
Tangible Book Value, 2 Yr. CAGR % | 41.47 | -13.28 | 5.01 | 62.53 | 57.18 | ||
Common Equity, 2 Yr. CAGR % | 113.55 | 161.82 | 27.6 | 14.54 | 7.6 | ||
Cash From Operations, 2 Yr. CAGR % | 35.25 | 57.42 | 32.09 | 23.88 | 16.14 | ||
Capital Expenditures, 2 Yr. CAGR % | 560.5 | 13.28 | -70.95 | 43.71 | 54.38 | ||
Levered Free Cash Flow, 2 Yr. CAGR % | - | -20.47 | 335.45 | 39.46 | 15.1 | ||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | -14.44 | 374.62 | 37.68 | 17.33 | ||
Compound Annual Growth Rate Over Three Years | |||||||
Total Revenues, 3 Yr. CAGR % | - | 31.17 | 25.85 | 19.69 | 20.49 | ||
Gross Profit, 3 Yr. CAGR % | - | 30.7 | 26.64 | 24.56 | 27.41 | ||
EBITDA, 3 Yr. CAGR % | - | 35.74 | 22.95 | 22.9 | 27.18 | ||
EBITA, 3 Yr. CAGR % | - | 36.44 | 22.8 | 22.85 | 27.11 | ||
EBIT, 3 Yr. CAGR % | - | 39.37 | 24 | 26.52 | 22.85 | ||
Earnings From Cont. Operations, 3 Yr. CAGR % | - | 37.31 | 40.24 | 59.53 | 9.47 | ||
Net Income, 3 Yr. CAGR % | - | -1.64 | -3.59 | 12.85 | 1.27 | ||
Normalized Net Income, 3 Yr. CAGR % | - | -15.95 | -5.71 | 9.72 | 57.14 | ||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | 80.27 | 116.9 | -3.45 | ||
Accounts Receivable, 3 Yr. CAGR % | - | 22.17 | 18.3 | 22.72 | 28.32 | ||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | 147.44 | 15.17 | 22.35 | 4.51 | ||
Total Assets, 3 Yr. CAGR % | - | 42.84 | 16.96 | 20.91 | 18.28 | ||
Tangible Book Value, 3 Yr. CAGR % | - | 19.82 | -1.18 | 31.43 | 46.89 | ||
Common Equity, 3 Yr. CAGR % | - | 85.15 | 100.17 | 22.22 | 10.65 | ||
Cash From Operations, 3 Yr. CAGR % | - | 30.92 | 52.18 | 23.48 | 24.26 | ||
Capital Expenditures, 3 Yr. CAGR % | - | 41.16 | 18.86 | -48.93 | 46.1 | ||
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | -0.94 | 199.87 | 25.07 | ||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | 3.38 | 212.73 | 27 | ||
Compound Annual Growth Rate Over Five Years | |||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | 26.49 | 24.12 | ||
Gross Profit, 5 Yr. CAGR % | - | - | - | 28.34 | 28.44 | ||
EBITDA, 5 Yr. CAGR % | - | - | - | 31.87 | 26.3 | ||
EBITA, 5 Yr. CAGR % | - | - | - | 32.25 | 26.29 | ||
EBIT, 5 Yr. CAGR % | - | - | - | 34.34 | 23.4 | ||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | 29.53 | 24.88 | ||
Net Income, 5 Yr. CAGR % | - | - | - | 8.09 | -1.42 | ||
Normalized Net Income, 5 Yr. CAGR % | - | - | - | 18.78 | 10.2 | ||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | - | 39.36 | ||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | 25.11 | 22.44 | ||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | 73.82 | 12.42 | ||
Total Assets, 5 Yr. CAGR % | - | - | - | 34.53 | 18.46 | ||
Tangible Book Value, 5 Yr. CAGR % | - | - | - | 35.36 | 18.97 | ||
Common Equity, 5 Yr. CAGR % | - | - | - | 52.79 | 56.16 | ||
Cash From Operations, 5 Yr. CAGR % | - | - | - | 28.06 | 36.59 | ||
Capital Expenditures, 5 Yr. CAGR % | - | - | - | 42.18 | 31.96 | ||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 6.81 | ||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 10.14 |
- Stock Market
- Equities
- RYAN Stock
- Financials Ryan Specialty Holdings, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















